Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03555799 · ClinicalTrials.gov registry record
Evaluation of Changes of Venous Return After Spinal and Epidural Analgesia and Anesthesia by Ultrasound Guided Vena Cava Diameter Measurement
A clinical trial, sponsored by Augusta University.
- Completed
- Registry status
- 42
- Enrollment target
NCT03555799: Completed study, sponsored by Augusta University.
NCT03555799 is a clinical trial that has completed, run by Augusta University. The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03555799 has completed, sponsored by Augusta University.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
Study Summary
The investigators propose this study to test the hypotheses that inferior vena cava (IVC) diameter can predict hypotension after labor analgesia (epidural, combined spinal-epidural) and neuraxial anesthesia for cesarean section (epidural, combined spinal-epidural and spinal block) in full-term pregnant patients.
Primary Outcome
IVC diameter in centimeters during respiratory cycle
Interventions
- DIAGNOSTIC_TEST Inferior vena cava ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2018-05-18 |
| Est. Completion | 2019-06-15 |
What the finished NCT03555799 record still lists
NCT03555799 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 42 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Inferior vena cava ultrasound is the first listed.
NCT03555799 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03555799 about?
NCT03555799 is a clinical study titled "Evaluation of Changes of Venous Return After Spinal and Epidural Analgesia and Anesthesia by Ultrasound Guided Vena Cava Diameter Measurement". The investigators propose this study to test the hypotheses that inferior vena cava (IVC) diameter can predict hypotension after labor analgesia (epidural, combined spinal-epidural) and neuraxial anesthesia for cesarean section (epidural, combined spinal-epidural and spinal block) in full-term pregn...
What is the current status of trial NCT03555799?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2018-05-18. Estimated completion is 2019-06-15.
What interventions are being tested in trial NCT03555799?
The interventions under investigation include: Inferior vena cava ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03555799?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI